Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RALLY-MF: A Phase 1b/2 Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of DISC-0974 in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia

NCT05320198 is registered in ClinicalTrials.gov with Disc Medicine, Inc as lead sponsor.

NCT NCT05320198
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05320198 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RALLY-MF: A Phase 1b/2 Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of DISC-0974 in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
Lead sponsor
Disc Medicine, Inc
Phase
Phase 1/2
Overall status
Recruiting
Start date
June 6, 2022
Completion date
June 30, 2027
Enrollment
150 (estimated)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

anemia, myelodysplastic syndromes, myelofibrosis, myelofibrosis due to and following polycythemia vera, myelofibrosis; anemia, post-essential thrombocythemia myelofibrosis, primary myelofibrosis